MASS(908 Devices Inc.) 的财务报表:医疗保健,医疗器械。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $42.21M | $46.85M | $50.23M | $47.75M | $56.20M |
| 毛利润 | $23.23M | $26.02M | $25.32M | $24.50M | $28.42M |
| 营业利润 | −$22.07M | −$35.38M | −$42.76M | −$57.39M | −$39.42M |
| 净利润 | −$22.17M | −$33.56M | −$36.40M | −$72.21M | $19.49M |
| 经营现金流 | −$29.08M | −$20.93M | −$25.06M | −$30.25M | −$23.69M |
| 自由现金流 | −$29.82M | −$22.98M | −$27.10M | −$30.85M | −$24.64M |
| 摊薄每股收益 | $-0.79 | $-1.07 | $-1.13 | $-2.12 | $0.54 |